Efficacy assessment of skin care product
- Registration Number
- CTRI/2024/02/062963
- Lead Sponsor
- Dabur India Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
2)Subject having dry skin on forearms
1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form.
2)Taking part in another study liable to interfere with this study.
3)Being known diabetic case
4)Known asthma case
5)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
6)Being known thyroid case
7)Being epileptic.
8)Following a chronic medicinal treatment comprising any of the following product: aspirin-based product, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
9)Known case of hypersensitivity.
10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic product.
11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
12)Having changed their cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
13)Having applied a cosmetic product (included make-up) on the studied areas 48 hours prior study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in skin MoisturizationTimepoint: Baseline, 30 minutes, 48 hours and 72 hours
- Secondary Outcome Measures
Name Time Method ilTimepoint: NA